moa of glp-1 agonists Glucagon-like peptide-1 receptor: mechanisms and advances in therapy What is GLP-1 and Its

Learn how this impacts injury risk, recovery, and long-term function.

Discover how GLP-1 and GLP-1/GIP therapies (semaglutide and tirzepatide) influence body composition

Our vision is a world free of MS.

About half support the use of GLP-1 weight loss drugs for adults with obesity or weight-related conditions, and a similar share the belief that these drugs should be covered by Medicare and Medicaid.

Trail registration Study registered in clinicaltrials.org with the identifier NCT05535322.

As a result, they are effective treatment options for people with T2D, achieving glycated haemoglobin reductions, weight loss and potential cardiovascular benefit, as monotherapy or as add-on to other glucose-lowering therapies